Connect with us

The Conversation

Cannabis-derived products like delta-8 THC and delta-10 THC have flooded the US market – two immunologists explain the medicinal benefits and potential risks

Published

on

Cannabis-derived products like delta-8 THC and delta-10 THC have flooded the US market – two immunologists explain the medicinal benefits and potential risks

Thousands of cannabis-derived products are now on the market.
skodonnell/E+ via Getty Images

Prakash Nagarkatti, University of South Carolina and Mitzi Nagarkatti, University of South Carolina

These days you see signs for delta-8 THC, delta-10 THC and CBD, or cannabidiol, everywhere – at gas stations, convenience stores, vape shops and online. Many people are rightly wondering which of these compounds are legal, whether it is safe to consume them and which of their supposed medicinal benefits hold up to scientific scrutiny.

The rapid proliferation of cannabis products makes clear the need for the public to better understand what these compounds are derived from and what their true benefits and potential risks may be.

We are immunologists who have been studying the effects of marijuana cannabinoids on inflammation and cancer for more than two decades.

We see great promise in these products in medical applications. But we also have concerns about the fact that there are still many unknowns about their safety and their psychoactive properties.

Parsing the differences between marijuana and hemp

Cannabis sativa, the most common type of cannabis plant, has more than 100 compounds called cannabinoids.

The most well-studied cannabinoids extracted from the cannabis plant include delta-9-tetrahydrocannabinol, or delta-9 THC, which is psychoactive. A psychoactive compound is one that affects how the brain functions, thereby altering mood, awareness, thoughts, feelings or behavior. Delta-9 THC is the main cannabinoid responsible for the high associated with marijuana. CBD, in contrast, is non-psychoactive.

Marijuana and hemp are two different varieties of the cannabis plant. In the U.S., federal regulations stipulate that cannabis plants containing greater than 0.3% delta-9 THC should be classified as marijuana, while plants containing less should be classified as hemp. The marijuana grown today has high levels – from 10% to 30% – of delta-9 THC, while hemp plants contain 5% to 15% CBD.

In 2018, the Food and Drug Administration approved the use of CBD extracted from the cannabis plant to treat epilepsy. In addition to being a source of CBD, hemp plants can be used commercially to develop a variety of other products such as textiles, paper, medicine, food, animal feed, biofuel, biodegradable plastic and construction material.

Recognizing the potential broad applications of hemp, when Congress passed the Agriculture Improvement Act, called the Farm Bill, in 2018, it removed hemp from the category of controlled substances. This made it legal to grow hemp.

When hemp-derived CBD saturated the market after passage of the Farm Bill, CBD manufacturers began harnessing their technical prowess to derive other forms of cannabinoids from CBD. This led to the emergence of delta-8 and delta-10 THC.

The chemical difference between delta-8, delta-9 and delta-10 THC is the position of a double bond on the chain of carbon atoms they structurally share. Delta-8 has this double bond on the eighth carbon atom of the chain, delta-9 on the ninth carbon atom, and delta-10 on the 10th carbon atom. These minor differences cause them to exert different levels of psychoactive effects.

Illustration of the chemical formula and structural composition of CBD versus delta9 THC.
Delta-9 THC is believed to be the primary cannabinoid that gives marijuana its psychoactive effects. Both CBD and marijuana have been shown in studies to be beneficial for various medicinal uses.
About time/iStock via Getty Images Plus

The properties of delta-9 THC

Delta-9 THC was one of the first forms of cannabinoid to be isolated from the cannabis plant in 1964. The highly psychoactive property of delta-9 THC is based on its ability to activate certain cannabinoid receptors, called CB1, in the brain. The receptor, CB1, is like a lock that can be opened only by a specific key – in this case, delta-9 THC – allowing the latter to affect certain cell functions.

Delta-9 THC mimics the cannabinoids, called endocannabinoids, that our bodies naturally produce. Because delta-9 THC emulates the actions of endocannabinoids, it also affects the same brain functions they regulate, such as appetite, learning, memory, anxiety, depression, pain, sleep, mood, body temperature and immune responses.

The FDA approved delta-9 THC in 1985 to treat chemotherapy-induced nausea and vomiting in cancer patients and, in 1992, to stimulate appetite in HIV/AIDS patients.

The National Academy of Sciences has reported that cannabis is effective in alleviating chronic pain in adults and for improving muscle stiffness in patients with multiple sclerosis, an autoimmune disease. That report also suggested that cannabis may help sleep outcomes and fibromyalgia, a medical condition in which patients complain of fatigue and pain throughout the body.
In fact, a combination of delta-9 THC and CBD has been used to treat muscle stiffness and spasms in multiple sclerosis. This medicine, called Sativex, is approved in many countries but not yet in the U.S.

Delta-9 THC can also activate another type of cannabinoid receptor, called CB2, which is expressed mainly on immune cells. Studies from our laboratory have shown that delta-9 THC can suppress inflammation through the activation of CB2. This makes it highly effective in the treatment of autoimmune diseases like multiple sclerosis and colitis as well as inflammation of the lungs caused by bacterial toxins.

However, delta-9 THC has not been approved by the FDA for ailments such as pain, sleep, sleep disorders, fibromyalgia and autoimmune diseases. This has led people to self-medicate against such ailments for which there are currently no effective pharmacological treatments.

Delta-8 THC, a chemical cousin of delta-9

Delta-8 THC is found in very small quantities in the cannabis plant. The delta-8 THC that is widely marketed in the U.S. is a derivative of hemp CBD.

Delta-8 THC binds to CB1 receptors less strongly than delta-9 THC, which is what makes it less psychoactive than delta-9 THC. People who seek delta-8 THC for medicinal benefits seem to prefer it over delta-9 THC because delta-8 THC does not cause them to get very high.

However, delta-8 THC binds to CB2 receptors with a similar strength as delta-9 THC. And because activation of CB2 plays a critical role in suppressing inflammation, delta-8 THC could potentially be preferable over delta-9 THC for treating inflammation, since it is less psychoactive.

There are no published clinical studies thus far on whether delta-8 THC can be used to treat the clinical disorders such as chemotherapy-induced nausea or appetite stimulation in HIV/AIDS that are responsive to delta-9 THC. However, animal studies from our laboratory have shown that delta-8 THC is also effective in the treatment of multiple sclerosis.

The sale of delta-8 THC, especially in states where marijuana is illegal, has become highly controversial. Federal agencies consider all compounds isolated from marijuana or synthetic forms, similar to THC, Schedule I controlled substances, which means they currently have no accepted medical use and have considerable potential for abuse.

However, hemp manufacturers argue that delta-8 THC should be legal because it is derived from CBD isolated from legally cultivated hemp plants.

YouTube video
In this California-based recreational and medical cannabis store, cannabis gummies are “easily” the most popular product.

The emergence of delta-10 THC

Delta-10 THC, another chemical cousin to delta-9 and delta-8, has recently entered the market.

Scientists do not yet know much about this new cannabinoid. Delta-10 THC is also derived from hemp CBD. People have anecdotally reported feeling euphoric and more focused after consuming delta-10 THC. Also, anecdotally, people who consume delta-10 THC say that it causes less of a high than delta-8 THC.

And virtually nothing is known about the medicinal properties of delta-10 THC. Yet it is being marketed in similar ways as the other more well-studied cannabinoids, with claims of an array of health benefits.

The future of cannabinoid derivatives

Research and clinical trials using marijuana or delta-9 THC to treat many medical conditions have been hampered by their classification as Schedule 1 substances. In addition, the psychoactive properties of marijuana and delta-9 THC create side effects on brain functions; the high associated with them causes some people to feel sick, or they simply hate the sensation. This limits their usefulness in treating clinical disorders.

In contrast, we feel that delta-8 THC and delta-10 THC, as well as other potential cannabinoids that could be isolated from the cannabis plant or synthesized in the future, hold great promise. With their strong activity against the CB2 receptors and their lower psychoactive properties, we believe they offer new therapeutic opportunities to treat a variety of medical conditions.The Conversation

Prakash Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina and Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Rethinking repression − why memory researchers reject the idea of recovered memories of trauma

Published

on

theconversation.com – Gabrielle Principe, Professor of Psychology, College of Charleston – 2025-03-24 07:52:00

Memories and photos both can misrepresent the past.
Westend61 via Getty Images

Gabrielle Principe, College of Charleston

In 1990, George Franklin was convicted of murder and sentenced to life in prison based on the testimony of his 28-year-old daughter Eileen. She described seeing him rape her best friend and then smash her skull with a rock.

When Eileen testified at her father’s trial, her memory of the murder was relatively fresh. It was less than a year old. Yet the murder happened 20 years earlier, when she was 8 years old.

How can you have a one-year-old memory of something that happened 20 years ago? According to the prosecution, Eileen repressed her memory of the murder. Then much later she recovered it in complete detail.

Can a memory of something so harrowing disappear for two decades and then resurface in a reliable form?

This case launched a huge debate between memory researchers like me who argue there is no credible scientific evidence that repressed memories exist and practicing clinicians who claim that repressed memories are real.

This controversy is not merely an academic one. Real people’s lives have been shattered by newly recollected traumatic experiences from childhood. I’ve seen this firsthand as a memory expert who consults on legal cases involving defendants accused of crimes they allegedly committed years or even decades ago. Often the only evidence linking the defendant to the crime is a recovered memory.

But the scientific community disagrees about the existence of the phenomenon of repressed memory.

Freud was the father of repression

Nineteenth-century psychoanalytic theorist Sigmund Freud developed the concept of repression. He considered it a defense mechanism people use to protect themselves from traumatic experiences that become too overwhelming.

The idea is that repression buries memories of trauma in your unconscious, where they – unlike other memories – reside unknown to you. They remain hidden, in a pristine, fixed form.

In Freud’s view, repressed memories make themselves known by leaking out in mental and physical symptoms – symptoms that can be relieved only through recovering the traumatic memory in a safe psychological environment.

In the 1980s, increasing numbers of therapists became concerned about the prevalence of child sexual abuse and the historical tendencies to dismiss or hide the maltreatment of children. This shift gave new life to the concept of repression.

Rise of repressed memory recovery

Therapists in this camp told clients that their symptoms, such as anxiety, depression or eating disorders, were the result of repressed memories of childhood sexual abuse that needed to be remembered to heal. To recover these memories, therapists used a range of techniques such as hypnosis, suggestive questioning, repeated imagining, bodywork and group sessions.

Did recovered-memory therapy work? Many people who entered therapy for common mental health issues did come out with new and unexpected memories of childhood sexual abuse and other trauma, without physical evidence or corroboration from others.

But were these memories real?

The notion of repressed memories runs counter to decades of scientific evidence demonstrating that traumatic events tend to be very well remembered over long intervals of time. Many victims of documented trauma, ranging from the Holocaust to combat exposure, torture and natural disasters, do not appear to be able to block out their memories.

In fact, trauma sometimes is too well remembered, as in the case of post-traumatic stress disorder. Recurrent and intrusive traumatic memories are a core symptom of PTSD.

No memory ≠ repressed memory

There are times when victims of trauma may not remember what happened. But this doesn’t necessarily mean the memory has been repressed. There are a range of alternative explanations for not remembering traumatic experiences.

Trauma, like anything you experience, can be forgotten as the result of memory decay. Details fade with time, and retrieving the right remnants of experience becomes increasingly difficult if not impossible.

Someone might make the deliberate choice to not think about upsetting events. Psychologists call this motivated forgetting or suppression.

There also are biological causes of forgetting such as brain injury and substance abuse.

Trauma also can interfere with the making of a memory in the first place. When stress becomes too big or too prolonged, attention can shift from the experience itself to attempts to regulate emotion, endure what’s happening or even survive. This narrow focus can result in little to no memory of what happened.

blank photo atop a stack of old black and white pictures
A forgotten memory isn’t just waiting around to be rediscovered – it’s gone.
malerapaso/E+ via Getty Images

False memories

If science rejects the notion of repressed memories, there’s still one question to confront: Where do newly recollected trauma memories, such as those triggered in recovered-memory therapy, come from?

All memories are subject to distortions when you mistakenly incorporate expectations, assumptions or information from others that was not part of the original event.

Memory researchers contend that memory recovery techniques might actually create false memories of things that never happened rather than resurrect existing memories of real experiences.

To study this possibility, researchers asked participants to elaborate on events that never happened using the same sorts of suggestive questioning techniques used by recovered-memory therapists.

What they found was startling. They were able to induce richly detailed false memories of a wide range of childhood traumatic experiences, such as choking, hospitalization and being a victim of a serious animal attack, in almost one-third of participants.

These researchers were intentionally planting false memories. But I don’t think intention would be necessary on the part of a sympathetic therapist working with a suffering client.

Are the memory wars over?

The belief in repressed memories remains well entrenched among the general public and mental health professionals. More than half believe that traumatic experiences can become repressed in the unconscious, where they lurk, waiting to be uncovered.

This remains the case even though in his later work, Freud revised his original concept of repression to argue that it doesn’t work on actual memories of experiences, but rather involves the inhibition of certain impulses, desires and fantasies. This revision rarely makes it into popular conceptions of repression.

As evidence of the current widespread belief in repressed memories, in the past few years several U.S. states and European countries have extended or abolished the statute of limitations for the prosecution of sexual crimes, which allows for testimony based on allegedly recovered memories of long-ago crimes.

Given the ease with which researchers can create false childhood memories, one of the unforeseen consequences of these changes is that falsely recovered memories of abuse might find their way into court – potentially leading to unfounded accusations and wrongful convictions.The Conversation

Gabrielle Principe, Professor of Psychology, College of Charleston

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Rethinking repression − why memory researchers reject the idea of recovered memories of trauma appeared first on theconversation.com

Continue Reading

The Conversation

How many types of insects are there in the world?

Published

on

theconversation.com – Nicholas Green, Assistant Professor of Biology, Kennesaw State University – 2025-03-24 07:48:00

This is a close-up photo of an ordinary garden fly.
Amith Nag Photography/Moment via Getty Images

Nicholas Green, Kennesaw State University

Curious Kids is a series for children of all ages. If you have a question you’d like an expert to answer, send it to CuriousKidsUS@theconversation.com.


How many types of insects are there in the world? – Sawyer, age 8, Fuquay-Varina, North Carolina


Exploring anywhere on Earth, look closely and you’ll find insects. Check your backyard and you may see ants, beetles, crickets, wasps, mosquitoes and more. There are more kinds of insects than there are mammals, birds and plants combined. This fact has fascinated scientists for centuries.

One of the things biologists like me do is classify all living things into categories. Insects belong to a phylum called Arthropoda – animals with hard exoskeletons and jointed feet.

All insects are arthropods, but not all arthropods are insects. For instance, spiders, lobsters and millipedes are arthropods, but they’re not insects.

Instead, insects are a subgroup within Arthropoda, a class called “Insecta,” that is characterized by six legs, two antennae and three body segments – head, abdomen and the thorax, which is the part of the body between the head and abdomen.

A diagram of an ant, pointing out various body parts, including the antennae, thorax and legs.
The mandibles of the ants are its jaws; the petiole is the ant’s waist.
Vector Mine/iStock via Getty Images Plus

Most insects also have wings, although a few, like fleas, don’t. All have compound eyes, which means insects see very differently from the way people see. Instead of one lens per eye, they have many: a fly has 5,000 lenses; a dragonfly has 30,000. These types of eyes, though not great for clarity, are excellent at detecting movement.

What is a species?

All insects descend from a common ancestor that lived about about 480 million years ago. For context, that’s about 100 million years before any of our vertebrate ancestors – animals with a backbone – ever walked on land.

A species is the most basic unit that biologists use to classify living things. When people use words like “ant” or “fly” or “butterfly” they are referring not to species, but to categories that may contain hundreds, thousands or tens of thousands of species. For example, about 18,000 species of butterfly exist – think monarch, zebra swallowtail or cabbage white.

Basically, species are a group that can interbreed with each other, but not with other groups. One obvious example: bees can’t interbreed with ants.

But brown-belted bumblebees and red-belted bumblebees can’t interbreed either, so they are different species of bumblebee.

Each species has a unique scientific name – like Bombus griseocollis for the brown-belted bumblebee – so scientists can be sure which species they’re talking about.

This close-up of a dragonfly reveals its blue head, bulging compound eyes and black antennae.
This is what a dragonfly looks like up close.
Dieter Meyrl/E+ via Getty Images

Quadrillions of ants

Counting the exact number of insect species is probably impossible. Every year, some species go extinct, while some evolve anew. Even if we could magically freeze time and survey the entire Earth all at once, experts would disagree on the distinctiveness or identity of some species. So instead of counting, researchers use statistical analysis to make an estimate.

One scientist did just that. He published his answer in a 2018 research paper. His calculations showed there are approximately 5.5 million insect species, with the correct number almost certainly between 2.6 and 7.2 million.

Beetles alone account for almost one-third of the number, about 1.5 million species. By comparison, there are “only” an estimated 22,000 species of ants. This and other studies have also estimated about 3,500 species of mosquitoes, 120,000 species of flies and 30,000 species of grasshoppers and crickets.

The estimate of 5.5 million species of insects is interesting. What’s even more remarkable is that because scientists have found only about 1 million species, that means more than 4.5 million species are still waiting for someone to discover them. In other words, over 80% of the Earth’s insect biodiversity is still unknown.

Add up the total population and biomass of the insects, and the numbers are even more staggering. The 22,000 species of ants comprise about 20,000,000,000,000,000 individuals – that’s 20 quadrillion ants. And if a typical ant weighs about 0.0001 ounces (3 milligrams) – or one ten-thousandth of an ounce – that means all the ants on Earth together weigh more than 132 billion pounds (about 60 billion kilograms).

That’s the equivalent of about 7 million school buses, 600 aircraft carriers or about 20% of the weight of all humans on Earth combined.

YouTube video
For every person on Earth, it’s estimated there are 200 million insects.

Many insect species are going extinct

All of this has potentially huge implications for our own human species. Insects affect us in countless ways. People depend on them for crop pollination, industrial products and medicine. Other insects can harm us by transmitting disease or eating our crops.

Most insects have little to no direct impact on people, but they are integral parts of their ecosystems. This is why entomologists – bug scientists – say we should leave insects alone as much as possible. Most of them are harmless to people, and they are critical to the environment.

It is sobering to note that although millions of undiscovered insect species may be out there, many will go extinct before people have a chance to discover them. Largely due to human activity, a significant proportion of Earth’s biodiversity – including insects – may ultimately be forever lost.


Hello, curious kids! Do you have a question you’d like an expert to answer? Ask an adult to send your question to CuriousKidsUS@theconversation.com. Please tell us your name, age and the city where you live.

And since curiosity has no age limit – adults, let us know what you’re wondering, too. We won’t be able to answer every question, but we will do our best.The Conversation

Nicholas Green, Assistant Professor of Biology, Kennesaw State University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post How many types of insects are there in the world? appeared first on theconversation.com

Continue Reading

The Conversation

Genomic sequencing reveals previously unknown genes that make microbes resistant to drugs and hard to kill

Published

on

theconversation.com – Nneka Vivian Iduu, Graduate Research Assistant in Pathobiology, Auburn University – 2025-03-24 07:48:00

Nneka Vivian Iduu, Auburn University

In the 20th century, when a routine infection was treated with a standard antibiotic, recovery was expected. But over time, the microbes responsible for these infections have evolved to evade the very drugs designed to eliminate them.

Each year, there are more than 2.8 million antibiotic-resistant infections in the United States, leading to over 35,000 deaths and US$4.6 billion in health care costs. As antibiotics become less effective, antimicrobial resistance poses an increasing threat to public health.

Antimicrobial resistance began to emerge as a serious threat in the 1940s with the rise of penicillin resistance. By the 1990s, it had escalated into a global concern. Decades later, critical questions still remain: How does antimicrobial resistance emerge, and how can scientists track the hidden changes leading to it? Why does resistance in some microbes remain undetected until an outbreak occurs? Filling these knowledge gaps is crucial to preventing future outbreaks, improving treatment outcomes and saving lives.

YouTube video
Antimicrobial resistance can be deadly.

Over the years, my work as a microbiologist and biomedical scientist has focused on investigating the genetics of infectious microbes. My colleagues and I identified a resistance gene previously undetected in the U.S. using genetic and computational methods that can help improve how scientists detect and track antimicrobial resistance.

Challenges of detecting resistance

Antimicrobial resistance is a natural process where microbes constantly evolve as a defense mechanism, acquiring genetic changes that enhance their survival.

Unfortunately, human activities can speed up this process. The overuse and misuse of antibiotics in health care, farming and the environment push bacteria to genetically change in ways that allow them to survive the drugs meant to kill them.

Early detection of antimicrobial resistance is crucial for effective treatment. Surveillance typically begins with a laboratory sample obtained from patients with suspected infections, which is then analyzed to identify potential antimicrobial resistance. Traditionally, this has been done using culture-based methods that involve exposing microbes to antibiotics in the lab and observing whether they survived to determine whether they were becoming resistant. Along with helping authorities and researchers monitor the spread of antimicrobial resistance, hospitals use this approach to decide on treatment plans.

However, culture-based approaches have some limitations. Resistant infections often go unnoticed until antibiotics fail, making both detection and intervention processes slow. Additionally, new resistance genes may escape detection altogether.

Genomics of antimicrobial resistance

To overcome these challenges, researchers have integrated genomic sequencing into antimicrobial resistance surveillance. Through whole-genome sequencing, we can analyze all the DNA in a microbial sample to get a comprehensive view of all the genes present – including those responsible for resistance. With the computational tools of bioinformatics, researchers can efficiently process vast amounts of genetic data to improve the detection of resistance threats.

Despite its advantages, integrating genomic sequencing into antimicrobial resistance monitoring presents some challenges of its own. High costs, quality assurance and a shortage of trained bioinformaticians make implementation difficult. Additionally, the complexity of interpreting genomic data may limit its use in clinical and public health decision-making.

Computer readout of rows of lines that peak at different heights at each G, T, A or C
Bioinformatics allows researchers to analyze large biological datasets.
hh5800/iStock via Getty Images Plus

Establishing international standards could help make whole-genome sequencing and bioinformatics a fully reliable tool for resistance surveillance. The World Health Organization recommends laboratories follow strict quality control measures to ensure accurate and comparable results. This includes using reliable, user-friendly computational tools and shared microbial databases. Additional strategies include investing in training programs and fostering collaborations between hospitals, research labs and universities.

Discovering a resistance gene

Combining whole genome sequencing and bioinformatics, my colleagues and I analyzed Salmonella samples collected from several animal species between 1982 and 1999. We discovered a Salmonella resistance gene called blaSCO-1 that has evaded detection in U.S. livestock for decades.

The blaSCO-1 gene confers resistance to microbes against several critical antibiotics, including ampicillin, amoxicillin-clavulanic acid and, to some extent, cephalosporins and carbapenems. These medications are crucial for treating infections in both humans and animals.

Microscopy image of two orange rods embedded in an irregularly shaped blue surface
Salmonella Typhimurium invading a cell.
NIAID/Flickr, CC BY-SA

The blaSCO-1 gene likely remained unreported because routine surveillance usually targets well-known resistance genes and it has overlapping functions with other genes. Gaps in bioinformatics expertise may have also hindered its identification.

The failure to detect genes like blaSCO-1 raises concern about its potential role in past treatment failures. Between 2015 and 2018, the Centers for Disease Control and Prevention began implementing whole-genome sequencing for routine surveillance of Salmonella. Studies conducted during this period found that 77% of multistate outbreaks were linked to livestock harboring resistant Salmonella.

These missed genes have significant implications for both food safety and public health. Undetected antimicrobial resistance genes can spread through food animals, contaminated food products, processing environments and agricultural runoff, allowing resistant bacteria to persist and reach humans. These resistant bacteria lead to infections that are harder to treat and increase the risk of outbreaks. Moreover, the global movement of people, livestock and goods means that these resistant strains can easily cross borders, turning local outbreaks into worldwide health threats.

Identifying new resistance genes not only fills a critical knowledge gap, but it also demonstrates how genomic and computational approaches can help detect hidden resistance mechanisms before they pose widespread threats.

Strengthening surveillance

As antimicrobial resistance continues to rise, adopting a One Health approach that integrates human, animal and environmental factors can help ensure that emerging resistance does not outpace humans’ ability to combat it.

Initiatives like the Quadripartite AMR Multi-Partner Trust Fund provide support for programs that strengthen global collaborative surveillance, promote responsible antimicrobial use and drive the development of sustainable alternatives. Ensuring researchers around the world follow common research standards will allow more labs – especially those in low- and middle-income countries – to contribute to global surveillance efforts.

The health of future generations depends on the world’s ability to ensure food safety and protect public health on a global scale. In the ongoing battle between microbial evolution and human innovation, vigilance and adaptability are key to staying ahead.The Conversation

Nneka Vivian Iduu, Graduate Research Assistant in Pathobiology, Auburn University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More

The post Genomic sequencing reveals previously unknown genes that make microbes resistant to drugs and hard to kill appeared first on theconversation.com

Continue Reading

Trending